Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program


Section Navigation
			
			CDC Home








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Sandia National Laboratories (Albuquerque, New Mexico)						Print
																Related Pages
										On This Page
			Special Exposure CohortWorker Outreach ActivitiesAdvisory Board Work GroupTechnical DocumentsAdvisory Board and NIOSH DiscussionsPublic Comments
		
(Site Profile/Docket Number 065)
Location: Albuquerque, New Mexico
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by The Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
There is currently one open/active SEC petition from the Sandia National Laboratories, Petition 188. The Secretary of the Department of Health and Human Services is reviewing all of the information submitted for the petition and will submit a decision to Congress. The Secretary’s decision takes effect in 30 calendar days after it is submitted to Congress, unless Congress states otherwise.
Class(es) Added to the SEC
All employees of the Department of Energy, its predecessor agencies, and its contractors and subcontractors who worked in any area at Sandia National Laboratories in Albuquerque, New Mexico, from January 1, 1949 through December 31, 1962, for a number of work days aggregating at least 250 work days, occurring either solely under this employment, or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.
**Note:** This class was established from Petition 162
All employees of the Department of Energy, its predecessor agencies, and their contractors and subcontractors who worked in any area at Sandia National Laboratories in Albuquerque, New Mexico, from January 1, 1963 through December 31, 1994, for a number of work days aggregating at least 250 work days, occurring either solely under this employment, or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.
**Note:** This class was established from Petition 188All employees of the Department of Energy, its predecessor agencies, and its contractors or subcontractors who worked in any area at the Sandia National Laboratories in Albuquerque, New Mexico, during the period from January 1, 1995, through December 31, 1996, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.
**Note:** This class was established from Petition 188
Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.
Petition 162 (Jan 1, 1957 to Dec 31, 1962)
	Petition 162 Information
Steps in Petition Process:
Petition Details:Date Received
January 19, 2010Date Qualified for Evaluation
April 13, 2010Summary of Information in Petition
**Job Titles and/or Job Duties:** All employees who worked within the Reactor Division
**Period of Employment:** January 1, 1957 through December 31, 1962
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
Sandia National Laboratories Petition 162
(January 1, 1957 through December 31, 1962)
Pages 1-35 [970 KB (35 pages)]
Pages 36-70 [887 KB (35 pages)]
Pages 71-105 [1 MB (35 pages)]
Pages 106-140 [1.3 MB (35 pages)]
Pages 141-171 [1 MB (31 pages)]Federal Register Notice Announcing that a Sandia National Laboratories SEC Petition has met the Minimum Qualifications for Review and Evaluation
April 28, 2010 [42 KB (1 page)]
(January 1, 1957 through December 31, 1962)SEC Petition Evaluation Report
May 6, 2011 [306 KB (60 pages)]
(January 1, 1949 through December 31, 1962)Evaluation Report Sent to the Advisory Board
May 6, 2011
(January 1, 1949 through December 31, 1962)Petition Discussed by the Advisory Board
The petition was discussed by the Advisory Board on May 25, 2011, during its regular meeting.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
July 8, 2011 [29 KB (2 pages)]
(January 1, 1949 through December 31, 1962)HHS Letters to Congress Regarding the SEC Petition
August 10, 2011 [78 KB (10 pages)]
(January 1, 1949 through December 31, 1962)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
July 29, 2011 [35 KB (5 pages)]
(January 1, 1949 through December 31, 1962)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination of a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
August 17, 2011 [38 KB (1 page)]
(January 1, 1949 through December 31, 1962)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
September 9, 2011
(January 1, 1949 through December 31, 1962)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
September 27, 2011 [44 KB (2 pages)]
(January 1, 1949 through December 31, 1962)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
September 15, 2011 [17 KB (1 page)]
(January 1, 1949 through December 31, 1962)
**Note:** This only applies if the class is added to the SEC.Petition 188 (Jan 1, 1963 to May 21, 2011)
	Petition 188 Information
Steps in Petition Process:
Petition Details:Date Received
July 18, 2011Date Qualified for Evaluation
October 21, 2011Summary of Information in Petition
**Job Titles and/or Job Duties:** All personnel who worked in any area
**Period of Employment:** January 1, 1963 through May 21, 2011
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
Sandia National Laboratories Petition [468 KB (8 pages)]
                (January 1, 1963 through May 21, 2011)Federal Register Notice Announcing that a Sandia National Laboratories SEC Petition has met the Minimum Qualifications for Review and Evaluation
November 14, 2011 [51 KB (1 page)]
                (January 1, 1963 through May 21, 2011)SEC Petition Evaluation Report
February 21, 2012 [975 KB (79 pages)]
                (January 1, 1963 through December 31, 1994)
Addendum July 26, 2018 [174 KB (19 pages)]
                (January 1, 1995 through December 31, 1996)
Addendum 2, April 1, 2019 [473 KB (52 pages)]
                (January 1, 1997 through May 21, 2011)Evaluation Report Sent to the Advisory Board
February 22, 2012
                (January 1, 1963 through December 31, 1994)
August 8, 2018 (Addendum)
                (January 1, 1995 through December 31, 1996)
April 2, 2019 (Addendum 2)
                (January 1, 1997 through May 21, 2011)Petition Discussed by the Advisory Board
The Advisory Board discussed this petition during its regular meetings on February 29, 2012; August 22, 2018; April 17, 2019; April 28, 2022; and August 17, 2022.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
April 9, 2012 [74 KB (2 pages)]
                (January 1, 1963 through December 31, 1994)
September 20, 2018 [122 KB (2 pages)]
                (January 1, 1995 through December 31, 1996)
September 5, 2022 [211 KB (1 page)]
                (January 1, 1997 through May 21, 2011)HHS Letters to Congress Regarding the SEC Petition
May 11, 2012 [269 KB (10 pages)]
                (January 1, 1963 through December 31, 1994)
October 18, 2018 [96 KB (12 pages)]
                (January 1, 1995 through December 31, 1996)
August 8, 2023 [287 KB (12 pages)]
                (January 1, 1997 through May 21, 2011)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
May 11, 2012 [103 KB (5 pages)]
                (January 1, 1963 through December 31, 1994)
October 18, 2018 [124 KB (4 pages)]
                (January 1, 1995 through December 31, 1996)
**Determination:**
August 8, 2023 [155 KB (4 pages)]
                (January 1, 1997 through May 21, 2011)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination Regarding a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
June 1, 2012 [46 KB (1 page)]
                (January 1, 1963 through December 31, 1994)
November 9, 2018 [104 KB (1 page)]
                (January 1, 1995 through December 31, 1996)
**Determination:**
September 22, 2023 [170 KB (1 page)]
                (January 1, 1997 through May 21, 2011)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
June 10, 2012
                (January 1, 1963 through December 31, 1994)
November 17, 2018
                (January 1, 1995 through December 31, 1996)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
June 29, 2012 [44 KB (1 page)]
                (January 1, 1963 through December 31, 1994)
December 14, 2018 [71 KB (1 page)]
                (January 1, 1995 through December 31, 1996)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
June 18, 2012 [16 KB (1 page)]
                (January 1, 1963 through December 31, 1994)
November 19, 2018 [93 KB (1 page)]
                (January 1, 1995 through December 31, 1996)
**Note:** This only applies if the class is added to the SEC.
SEC Petitions Not Qualifying for Evaluation
There were two additional petition received that did not qualify for evaluation. One petition did not meet the minimum petition requirements for evaluation, and the other was already included in the SEC.
Worker Outreach Activities
Based on a recommendation from the Advisory Board to provide workers and site experts with opportunities to participate in developing the technical documents used in dose reconstruction, NIOSH established a Worker Outreach Program.
At Worker Outreach Meetings, current and former DOE and AWE employees have opportunities to obtain information about Site Profiles, Technical Basis Documents, and Technical Information Bulletins, and to provide information for consideration and possible use in dose reconstruction. This process is valuable to ensure that the technical documents used in dose reconstruction contain correct and useful information.
Below are the Worker Outreach Activities for the Sandia National Laboratories:
**February 19, 2009**
            Meeting with Representatives of Office and Professional Employees International Union (OPEIU) Local 251; Albuquerque Metal Trades Council (MTC), AFL-CIO; Sandia Security Police Association; and New Mexico Building and Construction Trades Council, AFL-CIO
Final Minutes [49 KB (8 pages)]
**September 26, 2007**
            Meeting with New Mexico Building and Construction Trades Council, AFL-CIO, Albuquerque, New Mexico
Final Minutes [98 KB (24 pages)]
**September 25, 2007**
            Meeting with Office and Professional Employees International Union (OPEIU) Local 251 and Albuquerque Metal Trades Council (MTC), Albuquerque, New Mexico
Final Minutes [52 KB (9 pages)]
**August 15, 2005**
            Meeting with Security Police Association (Formerly IUPA Local 7002)
Final Minutes [52 KB (4 pages)]
**June 20, 2005**
            Meeting with Office and Professional Employees International Union Local 251; Albuquerque Metal Trades Council
Final Minutes [100 KB (17 pages)]
**June 20, 2005**
            Meeting with New Mexico Building and Construction Trades Council, Albuquerque, New Mexico
Final Minutes [61 KB (5 pages)]Advisory Board Work Group on Sandia National Laboratories
This Work Group is responsible for a review of the Sandia National Laboratories Site Profile and a review of the Site Profile by the Board’s contractor (SC&A). The Work Group shall consider issues identified by SC&A concerning the Site Profile and shall assist NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profile as appropriate.
**Work Group Members:**
Henry A. Anderson, M.D. (Chair)
Josie Beach
Genevieve S. Roessler, Ph.D.
Meeting Information:
**April 11, 2022**
            Teleconference Meeting of the Advisory Board’s Work Group on Sandia National Laboratories
Time/Location:
11:00 a.m. (Eastern Time)
                Meeting Type: Teleconference; Public, No Comment Period
Videoconference:
Join ZoomGov MeetingTeleconference Audio & Video
                    Meeting ID: 160 6763 3819
                    Passcode: ABRWH#01
Teleconference:
Phone: +1 (646) 828-7666 (U.S. East)Teleconference Phone
                    Phone: +1 (669) 254-5252 (U.S. West)Teleconference Phone
                    Meeting ID: 160 6763 3819
                    Passcode: 98685439Find your local number
One Tap Mobile:U.S. EastOne Tap MobileU.S. WestOne Tap Mobile
Join by H.323:
                        161.199.136.10 (U.S. East)
                        161.199.138.10 (U.S. West)
                        Meeting ID: 160 6763 3819
                        Passcode: 98685439

Join by Skype for Business: https://cdc.zoomgov.com/skype/16067633819
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [170 KB (1 page)]
Transcript [440 KB (78 pages)]
Discussion/Background Papers:
SC&A Presentation: SC&A Review of SEC-00188 Evaluation Report Addendum 2 for Sandia National Laboratories – Albuquerque [503 KB (25 pages)]
                    Presentation at the March 3, 2022, Teleconference Meeting of the Advisory Board’s Work Group on Sandia National Laboratories
SC&A Draft: Reply to NIOSH’s Response to SC&A’s Review of the Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 Evaluation Report [451 KB (25 pages)]
                    January 3, 2022
NIOSH/DCAS Presentation: Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 [1 MB (27 pages)]
                    Presentation at the March 3, 2022, Teleconference Meeting of the Advisory Board’s Work Group on Sandia National Laboratories
SC&A Draft: Review of SEC Petition Evaluation Report: Petition SEC-00188, Addendum 2 (1977–2011), for Sandia National Laboratories – Albuquerque [1 MB (63 pages)]
                    Contract No. 75D30119C04183
                    Document No. SCA-TR-2020-SEC004, Revision 0
                    December 4, 2020
**March 3, 2022**
            Teleconference Meeting of the Advisory Board’s Work Group on Sandia National Laboratories
Time/Location:
12:30 p.m. (Eastern Time)
                Meeting Type: Teleconference; Public, No Comment Period
Videoconference:
Join ZoomGov MeetingTeleconference Audio & Video
                    Meeting ID: 161 731 2093
                    Passcode: ABRWH#01
Teleconference:
Phone: +1 (646) 828-7666 (U.S. East)Teleconference Phone
                    Phone: +1 (669) 254-5252 (U.S. West)Teleconference Phone
                    Meeting ID: 160 6763 3819
                    Passcode: 98685439Find your local number
One Tap Mobile:U.S. EastOne Tap MobileU.S. WestOne Tap Mobile
Join by H.323:
                        161.199.136.10 (U.S. East)
                        161.199.138.10 (U.S. West)
                        Meeting ID: 160 6763 3819
                        Passcode: 98685439
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [172 KB (1 page)]
Transcript [167 KB (8 pages)]Presentations:
NIOSH/DCAS Presentation: Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 [1 MB (27 pages)]
SC&A Presentation: SC&A Review of SEC-00188 Evaluation Report Addendum 2 for Sandia National Laboratories – Albuquerque [503 KB (25 pages)]Discussion/Background Papers:
SC&A Draft: Reply to NIOSH’s Response to SC&A’s Review of the Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 Evaluation Report [451 KB (25 pages)]
                    January 22, 2022
SC&A Draft: Review of SEC Petition Evaluation Report: Petition SEC-00188, Addendum 2 (1977–2011), for Sandia National Laboratories – Albuquerque [1 MB (63 pages)]
                    Contract No. 75D30119C04183
                    Document No. SCA-TR-2020-SEC004, Revision 0
                    December 4, 2020
NIOSH/ORAU: SEC Petition Evaluation Report, Petition SEC-00188, Addendum 2 (1997-2011) [473 KB (52 pages)]
                    April 1, 2019
**August 13, 2018**
            Teleconference Meeting of the Advisory Board’s Work Group on Sandia National Laboratories
Time/Location:
2:00 p.m. Eastern Standard Time (EST)
            Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
            Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [30 KB (1 page)]
Transcript [165 KB (29 pages)]Presentations:
NIOSH/DCAS: Sandia National Laboratories – Albuquerque SEC-00188 Addendum [614 KB (20 pages)]Pre-Decisional Document Policy
Please note that as part of the procedures and processes of the Advisory Board’s Work Groups, several kinds of pre-decisional documents may be developed. These pre-decisional documents, such as white papers, matrices, working drafts, etc., are distributed among Work Group members as research and background tools to facilitate discussion and deliberation. Although discussion during a public meeting may cover pre-decisional documents, these documents often are not further revised or finalized, and thus do not reflect the final determination or evaluation of the Advisory Board and its Work Groups. Additionally, some pre-decisional documents not otherwise posted on the website may contain sensitive information, which would require an interested party to obtain such documents by filing a Freedom of Information Act (FOIA) request with the CDC/ATSDR FOIA office at foiarequests@cdc.gov.
Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile
Site Profile for Sandia National Laboratories in Albuquerque, New Mexico, and the Tonopah Test Range, Nevada [1.4 MB (120 pages)]
            Revised January 25, 2013
**Revision Includes:** Constitutes a total rewrite of the Site Profile. Details of the revision can be found on page 2 of the Site Profile, under the Publication Record section.
Technical Information Bulletins (TIBs)
ORAUT-OTIB-0072 Rev-00: External Coworker Dosimetry Data for the Sandia National Laboratories in Albuquerque, New Mexico [149 KB (12 pages)]
            September 26, 2008
**About this Document:** Provides information to allow dose reconstructors to assign doses at the Sandia National Laboratories in Albuquerque, New Mexico to certain workers who have no or limited monitoring data, based on site coworker data. No changes occurred as a result of formal internal and NIOSH review.Advisory Board and NIOSH Discussions on Sandia National Laboratories
The Sandia National Laboratories discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
SC&A Presentation: SC&A Review of SEC-00188 Evaluation Report Addendum 2 for Sandia National Laboratories – Albuquerque [254 KB (13 pages)]
            Presentation at the August 17-18, 2022, Teleconference Meeting of the Advisory Board on Radiation and Worker Health
SC&A Presentation: SC&A Review of SEC-00188 Evaluation Report Addendum 2 for Sandia National Laboratories – Albuquerque [336 KB (13 pages)]
            Presentation at the April 27-28, 2022, Teleconference Meeting of the Advisory Board on Radiation and Worker Health
NIOSH/DCAS Presentation: Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 [735 KB (23 pages)]
            Presentation at the April 27-28, 2022, Teleconference Meeting of the Advisory Board on Radiation and Worker Health
SC&A Presentation: SC&A Review of SEC-00188 Evaluation Report Addendum 2 for Sandia National Laboratories – Albuquerque [503 KB (25 pages)]
            Presentation at the March 3, 2022, Teleconference Meeting of the Advisory Board’s Work Group on Sandia National Laboratories
SC&A Draft: Reply to NIOSH’s Response to SC&A’s Review of the Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 Evaluation Report [451 KB (25 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2021-SEC006, Revision 0
            January 3, 2022
NIOSH/DCAS Presentation: Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 [1 MB (27 pages)]
            Presentation at the March 3, 2022, Teleconference Meeting of the Advisory Board’s Work Group on Sandia National Laboratories
SC&A Draft: SC&A’s Evaluation of ORAUT-OTIB-0049, Revision 02, “Estimating Doses for Plutonium Strongly Retained in the Lung” [1.3 MB (39 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2021-PR049, Revision 0
            October 7, 2021
SC&A Draft: SC&A’S Evaluation Of ORAUT-OTIB-0088, Revision 01, “External Dose Reconstruction” [296 KB (9 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2021-PR088, Revision 0
            September 3, 2021
NIOSH/ORAU: NIOSH Response to SC&A’s Review of SEC-00188 Sandia ER Addendum 2 [763 KB (21 pages)]
            May 3, 2021
SC&A Draft: Review of SEC Petition Evaluation Report: Petition SEC-00188, Addendum 2 (1977–2011), for Sandia National Laboratories – Albuquerque [1 MB (63 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2020-SEC004, Revision 0
            December 4, 2020
NIOSH/DCAS: Sandia National Laboratories – Albuquerque SEC-00188 Addendum 2 [571 KB (32 pages)]
            Presentation at the April 17, 2019, Advisory Board on Radiation and Worker Health Meeting
NIOSH/DCAS: Sandia National Laboratories – Albuquerque SEC-00188 Addendum [614 KB (20 pages)]
            Presentation at the August 13th, 2018, Advisory Board Work Group on Sandia National Laboratories and August 22, 2018, Advisory Board on Radiation and Worker Health meetings
NIOSH/DCAS: Sandia National Laboratory Special Exposure Cohort Petition SEC-00188 [672 KB (12 pages)]
            Presented at the December 13-14, 2017, Meeting of the Advisory Board on Radiation and Worker Health
Draft: Review of Site Profile for Sandia National Laboratories in Albuquerque, New Mexico, and the Tonopah Test Range in Nevada [421 KB (82 pages)]
            Contract No. 200-2009-28555
            Task Order No. 1
            SCA-TR-TASK1-0022
            February 12, 2009
Public Comments on Sandia National Laboratories Documents
How to Submit Comments
Comments on Sandia National Laboratories Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office
    Robert A. Taft Laboratories, MS-C34
    1090 Tusculum Avenue
    Cincinnati, OH 45226
    Please include the Site Profile/Docket Number (065) on all comments.
Comments Received
At this time, no comments have been submitted.
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue